All Featured Insights

CMS raises the bar for MA plan quality ratings, CVS announces corporate layoffs, and California passes healthcare AI legislation.

FTC sues PBMs over insulin pricing, a House bill would extend telehealth flexibilities, and HRSA awards contracts for the new organ transplant system.

HRSA warns Johnson & Johnson over 340B restrictions, a group of hospitals sues HHS to overturn DSH payment changes, and a CHS subsidiary expands its urgent care network.

The White House finalizes mental health parity rules, CMS notifies 1M beneficiaries of data breach, and Humana is exiting 13 MA markets.

CMS releases results from the first round of Medicare Drug Price Negotiations, Steward finds a buyer for its physician group, and employers are using price transparency data in their suits against Aetna.

CVS to roll out co-located Oak Street Health clinics amid reduced profit outlook, CMS finalizes inpatient payment rule that includes new mandatory bundled payment model, and an appeals court gives providers another win in No Surprises Act litigation.

Community Health Systems plans to sell its three Pennsylvania hospitals, a bankruptcy judge allows Steward Health Care to close two Massachusetts hospitals, and CMS approves North Carolina’s medical debt relief program.

The House Oversight Committee criticizes PBM pricing tactics, Humana’s CenterWell plans to open primary care centers at Walmarts, and a federal judge upholds the FTC’s noncompete rule, diverging from a previous district court ruling.

A judge orders a partial, preliminary injunction of the FTC’s noncompete ban, Sanford Health and Marshfield Clinic announce plans to combine, and CMS proposes a nearly 3% cut to Medicare physician pay for 2025.

SCOTUS dismisses the Idaho abortion law case, leaving the state’s emergency abortion ban paused, an appeals court mostly upholds the ACA preventive services mandate, and Cone Health plans to join Kaiser Permanente subsidiary Risant Health.

Novant cancels its plan to acquire two North Carolina hospitals from CHS amid an FTC challenge, Amazon expands its RxPass generic drug subscription service to Medicare, and the DOJ accuses two executives at telehealth startup Done of an Adderall distribution scheme.

An FDA advisory committee recommends approval of Eli Lilly’s Alzheimer’s drug, the Biden administration proposes banning medical debt from credit reports, and Elevance becomes the second insurer to win a MA star ratings lawsuit.